Foundation Medicine News and Activities
Presence
Headquarters: United States (USA)
Roche is one of the...
- Forbes Global 2000 (#80);
- Fortune 500 Europe (#44);
- Global Fortune 500 (#188);
- Russell 3000;
- Stoxx 600;
- Swiss market index;
- TOB Iconic 10,000.
Roche is a company listed under the stock ticker ROG (CH).
Roche has a direct presence in 22 countries.Roche has 43 subsidiaries including 89bio, Chugai Pharmaceutical and Flatiron Health.
They are in:
- Pharmaceuticals64%
- Biotechnology25%
- Other11%
Acquisition, funding and merger involving Roche.
- Roche has announced the acquisition of PathAI (posted on May 8 2026).
- Poseida Therapeutics and Roche have merged (posted on November 28 2024)..
Executives
View the org chart displaying its 20 main executives
Most searched biographies at Foundation Medicine
- Dan Malarek, Chief Executive Officer
- Troy Schurr, Chief Commercial Officer
- Jennifer Romans, Senior Vice President, Corporate Affairs
Popular executive movements at Foundation Medicine
- Mia Levy, Chief Medical Officer, has left the company (posted on October 6 2025).
Popular executive movements at Roche
- Erich Steiner has joined the company as Global Head, Logistics Procurement (posted on March 23 2026).
- Danielle Hartmann who was Global Head of Equity Strategy, becomes Head of Inclusion & Belonging International (posted on March 11 2026).
- Mark Dawson will join the company as Head o Pharma Research and Early Development on May 1, 2026 (posted on February 17 2026).
Click here to view some more movements at Roche
Create your alert
to follow the executive moves at Foundation Medicine.
Biotechnology
Roche has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Foundation Medicine
- Foundation Medicine Awards Grants to Organizations Addressing Disparities in Biomarker Testing for Breast and Prostate Cancer
- U.S. Food and Drug Administration Approves FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® (tepotinib) to Identify Patients with MET Exon 14 Skipping Alterations in Non-Small Cell Lung Cancer
- U.S. Food and Drug Administration Approves FoundationOne®Liquid CDx as a Companion Diagnostic for Itovebi™ (inavolisib) to Identify Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation
- Foundation Medicine Awarded Contract by the U.S. Department of Veterans Affairs to Provide Tumor Molecular Profiling to Veterans with Cancer
- U.S. Food and Drug Administration Approves FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for Lynparza® (olaparib) in Combination with Abiraterone for Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
- Foundation Medicine Partners with Syndax to Develop a Companion Diagnostic in Hematology and Support Efforts to Pursue Regulatory Approval for an Assay Based on the FoundationOne®Heme Platform
- Foundation Medicine Collaborates with Merus to Advance Treatment Options in NRG1 Fusion-Driven Tumors Using Foundation Medicine’s RNA Platform
- U.S. Food and Drug Administration (FDA) Approves FoundationOne®Liquid CDx as a Companion Diagnostic for AKEEGA® (niraparib and abiraterone acetate) for Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
- Foundation Medicine Announces Partnership with Repare Therapeutics to Provide Genomic Profiling Services to Support Clinical Trials and to Develop Companion Diagnostic for Lunresertib
- Foundation Medicine Launches RNA Sequencing Test, FoundationOne®RNA, in the U.S.
- View more press releases Close
Social media about Foundation Medicine
- Foundation Medicine on Wikipedia, Google News & Yahoo Finance
- Foundation Medicine on LinkedIn, X (Twitter) & YouTube
